Search alternatives:
significant barriers » significant barrier (Expand Search), significant factors (Expand Search), significant burden (Expand Search)
barriers decrease » larger decrease (Expand Search), barrier disease (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), teer decrease (Expand Search)
significant barriers » significant barrier (Expand Search), significant factors (Expand Search), significant burden (Expand Search)
barriers decrease » larger decrease (Expand Search), barrier disease (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), teer decrease (Expand Search)
-
1
-
2
-
3
Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers.
Published 2024“…The values are expressed as the means ± SDs and were analyzed according to the variance of the factorial design. **, *** and ****denote <i>p</i> < 0.01, < 0.001 and < 0.0001, respectively; ns = not significant.…”
-
4
CKO mice display decreased skin barrier function and perturbed homeostasis.
Published 2025Subjects: -
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
Published 2025“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”
-
14
-
15
-
16
-
17
-
18
B2 decreases glycolytic intermediates in cells.
Published 2025“…Other abbreviations: HGA, DL-hydroxyglutaric acid; PEP, phosphoenolpyruvic acid; 3-PGA, 3-phosphoglyceric acid; G3P; glyceraldehyde 3-phosphate; Data (n = 5) are shown as mean±SD. Not significant (ns): **<i>P</i> ≤ 0.01, ****<i>P</i> ≤ 0.0001by one-way ANOVA with multiple comparison of the mean of each test group to the mean of the vehicle control. …”
-
19
-
20